People
Anne Phelan
Dementia Discovery Fund scientific adviser and drug discovery executive; joined GSK in 2025 after scientific leadership roles at BenevolentAI and Pfizer.
Roles
Dementia Discovery Fund
CurrentScientific Advisory Board Member
People
Dementia Discovery Fund scientific adviser and drug discovery executive; joined GSK in 2025 after scientific leadership roles at BenevolentAI and Pfizer.
Scientific Advisory Board Member